Farhad Hafezi

Medical Director, The ELZA Institute, Zürich; Professor of Ophthalmology, Medical Faculty, University of Geneva; Clinical Professor of Ophthalmology, USC Gayle and Edward Roski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles

As a post-doc, Farhad Hafezi identified a gene that can completely inhibit light-induced retinal damage in mice. Today his clinical focus is on corneal and refractive laser surgery, and he is a pioneer of corneal collagen cross-linking (CXL) for the treatment of corneal ectatic disorders like keratoconus. Hafezi was instrumental in building IROC in Zurich, where CXL technology underwent clinical development, and is considered a leading expert on the development and translation of this technique, and its multiple applications in the field. A recipient of the Casebeer and ARVO Foundation/Carl Camras Translational Research Award awards, Hafezi founded the charitable Light for Sight Foundation, along with his wife, Nikki.

Part of the Power List 2016

Welcome to The Power List 2016 – our second foray into the Top 100 most influential people in the world of ophthalmology.

Though we realize our list can (and should) never be definitive, who can argue that the faces within – both familiar and new – do not beautifully highlight the brilliance and diversity found within the field?

Here, we celebrate 100 reasons to be proud of ophthalmology.

Go to The Power List 2016